Related Experiment Video
Updated: Oct 17, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Venous thromboembolism in patients with COVID-19 infection: risk factors, prevention, and management
Natasha Ahuja1, Jasmine Bhinder1, Jessica Nguyen1
1Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo General Medical Center/Kaleida Health, 100 High Street, B7, Buffalo, NY, 14203.
Insights
COVID-19 infections can lead to serious venous thromboembolic complications. This review covers COVID-19
Area of Science:
- Hematology, Infectious Diseases, Critical Care Medicine
Background:
- COVID-19 is associated with a significant risk of venous thromboembolic events (VTE).
- Understanding the pathophysiology and risk factors for VTE in COVID-19 is crucial for patient management.
Purpose of the Study:
- To provide a comprehensive summary of current knowledge on venous thromboembolism in COVID-19.
- To outline pathophysiology, risk factors, incidence, prophylaxis, and treatment of VTE in COVID-19 patients.
Main Methods:
- Review of current literature and data on venous thromboembolic complications in COVID-19.
- Synthesis of information on pathophysiology, risk factors, hematologic markers, incidence, timing, atypical presentations, and management strategies.
Main Results:
- COVID-19 patients exhibit unique risk factors and hematologic profiles associated with VTE.
- Specific incidence and timing patterns of venous events in COVID-19 have been observed.
- Atypical presentations of VTE can occur in the context of COVID-19.
Conclusions:
- Venous thromboembolism is a critical concern in COVID-19 management.
- Evidence-based prophylaxis and therapeutic recommendations are essential for mitigating VTE risk.
- Ongoing research is vital as understanding of COVID-19-associated VTE continues to evolve.
Abstract:
Venous thromboembolic complications have emerged as serious sequelae in COVID-19 infections. This article summarizes the most current information regarding pathophysiology, risk factors and hematologic markers, incidence and timing of events, atypical venous thromboembolic complications, prophylaxis recommendations, and therapeutic recommendations. Data will likely to continue to rapidly evolve as more knowledge is gained regarding venous events in COVID-19 patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction

